FDA Approved: ARYNTA — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ARYNTA (lisdexamfetamine dimesylate oral) from Azurity Pharmaceuticals under an Original Application NDA. This entry documents the approval status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• ARYNTA (LISDEXAMFETAMINE DIMESYLATE ORAL)

Snippet

ORIG AP for ARYNTA (LISDEXAMFETAMINE DIMESYLATE ORAL)